Axel Bolte's Net Worth
$1.17 Million
Who is Axel Bolte?
Axel Bolte has an estimated net worth of $1.17 Million. This is based on reported shares across multiple companies, which include Inozyme Pharma, Inc., Ophthotech Corp., PTC THERAPEUTICS, INC., Nabriva Therapeutics AG, and Allena Pharmaceuticals, Inc..
SEC CIK
Axel Bolte's CIK is 0001579247
Past Insider Trading and Trends
2021 was Axel Bolte's most active year for acquiring shares with 6 total transactions. Axel Bolte's most active month to acquire stocks was the month of April. 2023 was Axel Bolte's most active year for disposing of shares, totalling 9 transactions. Axel Bolte's most active month to dispose stocks was the month of June. 2013 saw Axel Bolte paying a total of $300,000.00 for 20,000 shares, this is the most they've acquired in one year. In 2013 Axel Bolte cashed out on 2,000 shares for a total of $44,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98
Chief Executive OfficerAxel Bolte owns 266,696 units of Common Stock which is worth $1,328,146.08. From 2022 to 2024 Axel Bolte acquired a total of 142,659 shares in Inozyme Pharma, Inc. at a cost of $333,629.20, Axel also disposed a total of 66,788 shares of Inozyme Pharma, Inc. equalling to $6.68.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +1.84% | 4.81K |
$2.21 | $10,621.26 | 266.7K |
Mar 31
| |||
Form 4
| +1.28% | 3.31K |
$2.28 | $7,558.20 | 261.89K |
Sep 30
| |||
Form 4
| +35.50% | 67.75K |
$3.69 | $249,997.50 | 258.57K |
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
$0.98 | $65,445.56 | 190.82K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ophthotech Corp. No price found
InvestorAxel Bolte used to own units in Common Stock but no longer holds any shares there. In the year 2013 Axel Bolte filed a total of 14 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.09K |
—
|
—
|
0
|
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +194.51% | 14.59K |
—
|
—
| 22.09K |
May 11
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
May 11 - May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -100.00% | -6.00K |
$4.83 | -$28,980.00 |
0
|
Dec 30
| |||
Form 4
| +140.00% | 3.5K |
$56.97 | $199,395.00 | 6K |
Jun 3
| |||
Form 4
| +25.00% | 500 |
$48.27 | $24,135.00 | 2.5K |
Mar 30
| |||
Form 4
| -50.00% | -2.00K |
$22.00 | -$44,000.00 | 2K |
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PTC THERAPEUTICS, INC. (PTCT) Snapshot price: $31.54
InvestorAxel Bolte owns 20,000 units of Common Stock which is worth $630,800.00. In the year 2013 Axel Bolte filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 20K |
$15.00 | $300,000.00 | 20K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nabriva Therapeutics AG (NBRVF) Snapshot price: $0.00001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allena Pharmaceuticals, Inc. (ALNAQ) Snapshot price: $0.0065
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||